Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PHA333 > transdermal drug delivery > Flashcards

transdermal drug delivery Flashcards

1
Q

What is transdermal delivery?

A

delivery of drug across the stratum corneum and into the systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is topical drug delivery?

A

delivery of a drug across the stratum corneum and into the deeper skin skin layers for local action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

advantages of transdermal route vs oral/IV route

A
  • controlled release of drug into systemic circulation (dec dose frequency)
  • avoidance of liver metabolism (inc bioavailability, admin of a lower dose)
  • safer (no GI s/e)
  • patient compliane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

limitations of transdermal route vs oral/IV route

A
  • permeability barrier (only small, lipophilic molecules can permeate through skin)
  • low dose delivery (potent molecules)
  • inter and intra patient variability (wide therapeutic window)
  • skin irritation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3 layers of skin

A

epidermis
dermis
subcutaneous fat tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

main barrier to drug transport across the skin

A

stratum corneum (SC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How are drugs removed from the skin?

A

blood supply in dermis

  • conc gradient between drug on skin surface and the dermal vasculature
  • driving force for diffusion across the skin membrane
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

steps for drug delivery via the skin

A
  • dissolved drug molecules diffuse along the vehicle towards the vehicle/skin interface
  • partitioning of drug from vehicle into SC, diffusion through SC
  • partitioning from SC into viable epidermis, diffusion through viable epidermis (aqueous)
  • partition from epidermis into dermis, diffusion through dermal tissue
  • partition into capillaries and removal by systemic circulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

other fates of drug delivery via skin

A
  1. '’reservoir effect’’ - drug binds to keratins in SC
  2. enzymatic metabolism - drug degradation or activation (pro-drug) by skin enzymes in viable epidermis
  3. partitioning into subcutaneous fatty layers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

structure of stratum corneum

A
  1. corneocytes - differentiated keratinocytes
  2. intercellular lipid domain - ceramides, FAs, cholesterol
  • > no phospholipids, ceramides insetad
  • > ceramined only in lipids in skin, no where else in body
  • > '’brick and mortar’’ structure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

intercellular pathway through stratum corneum

A
  • diffusion via the intercellular lipid domain
  • main pathway for small, uncharged, lipophilic molecules
  • pathlength of permentation 500 microm > thickness of SC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

intracellular/transcellular pathway through stratum corneum

A
  • sequential partition and diffusion across the corneocytes

- pathlength of permeation = thickness of SC (20 microm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

appendageal transport in stratum corneum (hair follicles, sweat/oil glands)

A
  • significant in vivo contribution

- important for large, polar molecules and ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is diffusion of a drug in transdermal delivery?

A

spontaneous flow of molecules across an area

from a region of high concentration to a region of lower concentration, driven by a concentration gradient

slow, random movement - Brownian motion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mr of a drug and its diffusion through SC

A

larger = slower diffusion through SC

smaller = higher diffusion coefficient, faster

-> low Mr drugs best for transdermal dosage forms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

temperature and diffusion coefficient of drug transdermally

A

higher/inc T of skin = higher/inc diffusion coefficient, quicker drug release

  • > can casue s/e if it exceeds MSC
    eg. fentanyl patches, inc skin temp will inc diffusion of drug and can cause side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ideal properties of a drug for passive transdermal delivery

A
  1. therapeutic properties

2. physiochemical properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

therapeutic properties of drug for passive transdermal delivery

A

low daily dose (<10mg/day)

short half life (<10hrs)

non-irritating/sensitising to skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

physiochemical properties of drug for passive transdermal delivery

A 
low Mr (<500 Da)
- D (diff coeff) inversely proportional to molecular size of drug

aqueous solubility
- needs >1mg/ml to be removed by blood supply

optimal partition coefficient K

  • lipid solubility to diffuse across SC
  • logK o/w = 1-3

low melting point (<200 degC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

methods to increase drug diffusion via skin

A
  1. prodrug
  2. super-saturation
  3. chemical enhancers
  4. eutectic mixtures
  5. colloidal drug cerrier systems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

prodrug approach

A

hydrophilic drugs to lipophilic prodrug

  • attach lipophilic fxn group (ester group)
  • prodrug has optimal K
  • prodrug converted to active drug by enzymes in viable epidermis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

examples of prodrug approach

A

topical anti-inflammatory steroids

  • betamethasone 17 valerate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

problem with using prodrug approach

A

needs extra toxicological studies - new chemical entity being made

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

super-saturation approach

A

max flux (Jmax) when Cv = Cmax

Cmax = max sol of drug vehicle = saturation conc of a drug in vehicle (dissolved drug molecules are in equilibrium with solid drug

but will create an unasable formulation, high tendency to crystlalise
-> add anti-nucleating excipients to prevent drug crystallisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
use of chemical enhancers
diffuse into the skin and reversibly alter the properties of the stratum corneum inc D - disrupt packing of the lipid bilayers - disrupt protein structure alter K - change the solvent nature of stratum corneum
26
ideal properties of chemical enhancers
- pharmacologically inactive, non-toxic/allergenic, compatible with drug - immediate and reversible effect - unidirectional action
27
problems with chemical enhancers
safety issues can be toxic, need to use in low concs for formulation
28
What is a eutectic mixture?
mixture of drug with another component at a certain ratio where they inhibit crystallisation of each other - stable formulation - eutectic system has a lower MP than either of the 2 components
29
''ideal solution theory''
the lower the MP of the drug the higher its solubility in the stratum corneum lipids
30
MP for drugs for eutectic mixtures
< 200 degC using eutectis mixture at or below 32 degC (skin temp) is desirable because it results in a liquid eutectis mixture
31
examples of eutectic mixtures
ibuprofen-thymol lidocaine-menthol testosterone-menthol lidocaine-prilocaine (EMLA cream)
32
3 types of colloidal drug carrier systems
1. liposomes 2. ethosomes 3. transfersomes
33
liposomes for colloidal drug carrier systems
modify lipid component to imitate stratum corneum lipids - ceramides ('cerasomes') topical delivery - reservoir formation in stratum corneum not effective for transdermal delivery
34
ethosomes in colloidal drug carrier systems
liposomes with 30% ethanol enhance transdermal delivery
35
transdersomes for colloidal drug carrier systems
elastic liposomes - phospholioid + surfactant + ethanol squeeze through pores in stratum corneum move across hydration gradient - non occlusive vehicle (move from dry to moist surface)
36
What are transdermal drug delivery patches?
flexible pharmaceutical preparations containing one or more active substances, intended to be applied on unbroken skin in order to deliver the active substances to the systemic circulation after passing through the skin barrier forumlated med deviced that allow controlled release of drug from intact skin surface into systemic circulation applied for 1-7 days
37
patch components
backing layer liner adhesive (pressure sensitive adhesive) optional: membrane matrix polymer
38
backing layer of a patch
protects patch components from environment throughout application - occlusive (low water vapour transmission) - flexibility
39
liner of a patch
- polymer material, covers adhesive - removed to allow patch application onto skin - occlusive, min loss of volatile patch components
40
adhesive of a patch
- attaches patch to skin - common polyers - acrylic, polyisobutylene, silicone - visco-elastic material - may contain the drug and excipients
41
membrane of patch (optional)
- reservoir patch design - moderates the rate of drug release from drug reservoir into the adhesive layer - steady state drug release
42
matrix polymer of a patch (optional)
layer containing drug dispersed or dissolved in a polymer matrix
43
QC tests
- uniformity of dosage units - uniformity of content - dissolution - adhesive performance
44
drug release patterns of transdermal delivery
1. reservoir (membrane controlled system) - steady state release 2. drug in adhesive and matrix systems - Higuchi sq root of time fxn, assuming drug in suspension
45
When to use diffusion cells (Franz cells)?
for in vitro drug release studies
46
How do diffusion/Franz cells work?
- dosage form applied on donor compartment - membrane can be artificial or human/animal skin - samples are collected for analysis at regular intervals
47
tests for adhesive performance
peel test tack test rheological criteria for adhesive performance
48
Why to use active transdermal drug delivery?
- drugs that can't be delivered by passive diffusion | - increase the drug transoport rate
49
How to create active transport drug delivery?
- increasing the energy of drug molecules -> iontophoresis, electroporation, sonophoresis - bypassing or removing skin barrier -> stratum corneum bypass or removal
50
iontophoresis
- movement of molecules across the skin under the influence of an electrical field - broad range of drugs, ideally charged molecules - use of low voltage electrical current <1V - ionophoretic drug transport rate > passive transport rate - drug transport rate can be monitored by adjusting the electrical current
51
3 parts to iontophoretic patch
1. drug reservoir - aqueous, biocompatible gel - pH to optimise iontophoretic delivery and skin tolerance - +ve drug at anode, -ve drug at cathode 2. return reservoir - saline and charged molecules to complete circuit 3. electronic controller - battery and monitor
52
2 methods of iontophoretic drug transport
1. electrophoretic mechanism | 2. electro-osmotic mechanism
53
electrophoretic mechanism of iontophoretic drug transport
transport of molecules under direct interaction with electric firle charged molecules of low MW
54
electro-osmotic mechanism of iontophoretic drug transport
transport of molecules under the influence of the electrically induced solvent flow solvent flow - flux of skin caitons from anode to cathode uncharged, large molecules eg. peptides, +ve charged drug molecules
55
E-TRANS Fentanyl system
24hr administration up to 6 times/hr pain relief within a few mins after pressing button
56
electroporation
formation of transient aqueous pores in the skin by short electrical pulses of high voltage electrical currents 100-1000 volts electric field within the stratum corneun - pain free disrutpion of lipid structure of stratum corneum reversibility of effect from seconds to hrs possible skin damage
57
sonophoresis
low frequency ultrasonic energy (20 kHz) thermal effect by absorption of ultrasound 'fluid velocity' - acoustic streaming disruption of lipid packing by cavitation deactivation of skin enzymes safety and effectiveness issues
58
microneedles
micrometer silicon needles or biodegradable needles don't reach dermis - pain free pre-treatment of skin/drug admin device needles can be drug coated OR drug loaded
59
Macroflux microneedle system
needles drug coated can use any type of drug
60
PowderJect system
supersonic wave of helium gas solid drug particles (20-100um, micronised) fired into lower skin layers into systemic circulation
61
laser ablation
partial/complete removal of stratum corneum used for cosmetic resurfacing of skin specialist practitioner reversile technique - skin regeneration
62
combination strategies
active with passive transport enhancement synergistic effect

PHA333 (27 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions